S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trials.

@article{Rohde2011S100A1GT,
  title={S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trials.},
  author={David Rohde and Henriette L Brinks and Julia Ritterhoff and Gang Qui and Shumei Ren and P. F. J. van der Most},
  journal={Journal of molecular and cellular cardiology},
  year={2011},
  volume={50 5},
  pages={777-84}
}
Representing the common endpoint of various cardiovascular disorders, heart failure (HF) shows a dramatically growing prevalence. As currently available therapeutic strategies are not capable of terminating the progress of the disease, HF is still associated with a poor clinical prognosis. Among the underlying molecular mechanisms, the loss of cardiomyocyte Ca(2+) cycling integrity plays a key role in the pathophysiological development and progression of the disease. The cardiomyocyte EF-hand… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 60 references

Cardiac adenoviral S100A1 gene transfer rescues failing myocardium

  • P Most, ST Pleger, M Völkers, B Heidt, M Boerries, D Weichenhan
  • J Clin Investig
  • 2004
Highly Influential
4 Excerpts

S 100 A 1 : a regulator of striated muscle sarcoplasmic reticulum Ca 2 + handling , sarcomeric , and mitochondrial function

  • P Most, WJ Koch
  • J Biomed Biotechnol
  • 2010

Titin - isoform dependence of titin – actin interaction and its regulation by S 100 A 1 / Ca 2 + in skinned myocardium

  • MM LeWinter, H Granzier
  • J Biomed Biotechnol
  • 2010

Similar Papers

Loading similar papers…